Clinical Trials Logo

Burns clinical trials

View clinical trials related to Burns.

Filter by:
  • Withdrawn  
  • Page 1 ·  Next »

NCT ID: NCT04951934 Withdrawn - Burns Clinical Trials

Prospective Randomized International Study on the Reactivation of Burn Injuries

SPRINT
Start date: January 2023
Phase: N/A
Study type: Interventional

This clinical trial will be a multi-centric prospective, randomized controlled study with the commercial objective of evaluating the clinical efficacy of a battery-powered portable device that uses blue LEDs. The clinical study aims to compare the existing standard treatment for burned areas in which the autologous skin graft was not successful, with a protocol that includes the administration of the treatment with EmoLED for 5 consecutive weeks in addition to conventional therapy. The enrolled patients will have to be examined after 5 weeks of treatment, until complete healing and subsequently their scarring will have to be evaluated at 3 and 6 months after healing.

NCT ID: NCT04684121 Withdrawn - Thermal Burn Clinical Trials

Study of the Efficacy and Safety of Granexin® Gel to Improve Burn Wound Healing

Start date: August 1, 2022
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy of Granexin® gel to promote accelerated healing of second-degree (deep partial thickness) thermal burns.

NCT ID: NCT04673435 Withdrawn - Full Thickness Burn Clinical Trials

Permeaderm Versus Homograft for Full-thickness Burns

Start date: January 31, 2018
Phase: N/A
Study type: Interventional

Frozen Human Cadaver Allograft (FHCA) is, nowadays, the gold standard for temporary coverage of excised full-thickness burns, but is also very expensive and requires additional personnel and major storage spaces in comparison to other products. The purpose of this study is to determine the extent to which PermeaDerm® dressing promotes wound bed maturation when used as a temporary dressing for excised full-thickness burn wounds. Efficacy and safety in promoting wound bed maturation for successive autografting will be determined through direct comparison to FHCA.

NCT ID: NCT04502914 Withdrawn - Burns Clinical Trials

The Study on Bacterial Load Following Open-to-air Management in Burn Patients.

Start date: November 1, 2020
Phase: N/A
Study type: Interventional

Burns are one of the common forms of trauma and are a cause of unintentional death and injury. Management of burns becomes complex due to multiple associated complications, for instance, secondary infection of burn wounds is the most common complication associated with burn injuries. Treatment of bacterial infections with antibiotics is becoming more challenging due to the development of multidrug-resistance. Hence, there is a critical need to investigate and establish non-antibiotic approaches to prevent colonization, control growth, and eliminate bacteria from burn wounds. Recent studies have explored the beneficial effects of open-to-air strategies on wound healing. Based on the evidence, the investigators hypothesize that bacterial load in burn wounds will be lowered when treated with an open-to-air strategy compared to the traditional closed wound approach.

NCT ID: NCT04162639 Withdrawn - Burns Clinical Trials

The Relationship Between Cadaveric Allograft Skin and HLA-Sensitivity in Burn Patients

Start date: February 2021
Phase: Phase 4
Study type: Interventional

The purpose of this research study is to look at how the body's immune system reacts to temporary skin grafts from deceased donors.

NCT ID: NCT04149808 Withdrawn - Second-degree Burn Clinical Trials

Mepilex Ag vs. Xeroform in Pediatric Patients That Sustain Partial Thickness Burn Injury

Start date: November 1, 2019
Phase: N/A
Study type: Interventional

Pediatric patients that sustain partial thickness burn injuries to their extremities require regular scheduled dressings and weekly appointments for better healing. Typically, the dressing used at Children's Hospital of Michigan is Xeroform, which can often be painful when changing at the weekly clinic appointment. Mepilex Ag is also an approved treatment for these types of burns and has the potential to cause less pain with dressing changes, however is not used as frequently due to a much higher cost. Studies evaluating the treatment of partial thickness burns in pediatric patients have shown decreased cost and length of stay associated with dressings that are silver impregnated, like Mepilex Ag. However, these studies are all retrospective with a possible selection bias to patients. In addition, several studies have suggested less pain with newer foam and hydrofiber dressings. We are conducting a prospective study using patients with partial thickness burns of their extremities, applying Xeroform on half of the burn, and Mepilex Ag on the other half of the burn, to remove confounding variables between patients to determine the optimal burn dressing for partial thickness scald burns for pediatric patients. A partial thickness burn, also known as a second degree burn, extends into the top two layers of the skin, not passing the hypodermis. Our goal is to determine if Xeroform or Mepilex Ag is superior treatment for partial thickness burns in pediatric patients for healing time, appearance of scar, and patient pain and comfort during treatment and dressing changes.

NCT ID: NCT04084093 Withdrawn - Burns Clinical Trials

Evaluating the Use of a Concentrated Surfactant Gel in Burn Patients

Start date: February 12, 2020
Phase: N/A
Study type: Interventional

This will be an observational study evaluating subject's perception of pain to dressing changes during removal and application of a surfactant gel. Wound healing will also be monitored. Anxiety before dressing change will be measured using a burn specific pain anxiety scale. Study intervention will include cleansing the wound per the facility's standard of care, followed by applying the investigational product on the wound. This will be followed by placing an appropriate secondary dressing.

NCT ID: NCT03924908 Withdrawn - Anxiety Clinical Trials

Impact of Virtual Reality Hypnosis on Pain and Anxiety During Dressings Change in Burn Patients

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

Different non-pharmacological techniques, including hypnosis and virtual reality are currently used as complementary tools in the treatment of pain related to burn injury. A new technique called 'virtual reality hypnosis' (VRH) (Patterson et al., 2004), which encompasses a combination of both tools, is regularly used although its actual function remains unknown to this date. With the goal to improve our understanding of VRH combination effects, it is necessary to elaborate randomized and controlled research studies in order to understand their actual function in individual's perception. 100 patients who are treated as outpatients for burn care will be randomly assigned to virtual reality or VRH. Patients will receive one session of one of these techniques during burn dressing change.Physiological parameters will be recorded during dressing change. Participants will fill in a questionnaire evaluating their tendency to be absorbed and dissociated, and another evaluating their level of perceived immersion. Their level of anxiety, pain, fatigue and relaxation will be evaluated before and after the session. A short interview will also be conducted to give participants the opportunity to openly describe their experience.

NCT ID: NCT03816384 Withdrawn - Surgery Clinical Trials

Effect of Active Drain Line Clearance on Catheter-Associated Bacteriuria

CAB
Start date: January 31, 2020
Phase: N/A
Study type: Interventional

Catheter-associated urinary tract infections (CAUTI) are the most common nosocomial infections in critically ill patients and are responsible for high morbidity rates, increased hospital stays and associated costs. The purpose of this study is to evaluate whether active drain line clearance by the Accuryn Monitoring System reduces the incidence of CAUTI in hospitalized patients requiring catheters.

NCT ID: NCT03675568 Withdrawn - Burn Wound Clinical Trials

Non-cultured Autologous Keratinocyte Suspension Versus Traditional Split Skin Graft for Burn Wounds Treatment

Start date: November 1, 2018
Phase: N/A
Study type: Interventional

A study comparing effect of non-cultured autologous keratinocyte suspension on burn wounds treatment compared with traditional split skin graft